New Product Planning: Am I Doing It Right?

Planning a new product launch can be challenging. From assessing market needs to aligning cross-functional teams, companies must follow proven strategies to ensure a smooth, successful launch that meets commercial and compliance expectations.

Levers for Launch: How Kadcyla Leveraged Post-Launch Evidence to Secure Standard-of-Care Status in HER2+ Breast Cancer

Novel therapies entering established oncology markets face steep adoption barriers when clinical pathways are already entrenched. Overcoming this resistance requires securing a strategic beachhead: a targeted focus area used to establish initial adoption and secure market traction, such as embedding into clinical pathways, managing safety expectations, or expanding into earlier lines of therapy through post-launch […]

Levers for Launch: How Vyndamax Built a Diagnostic Market to Establish Standard of Care in ATTR-CM

Novel therapies entering overlooked disease categories often encounter steep adoption barriers when conditions remain underdiagnosed and unfamiliar to prescribers. Overcoming this resistance requires securing a strategic beachhead: a targeted focus area used to establish initial adoption and secure market traction, such as building diagnostic pathways, educating specialists on disease recognition, or establishing outcomes-based agreements with […]

Levers for Launch: How Repatha Overcame Payer Barriers to Drive Market Adoption in Cardiovascular Care

Clinically differentiated therapies entering mature markets often face steep adoption resistance when high launch prices collide with aggressive payer restrictions. Overcoming this friction requires securing a strategic beachhead: a targeted focus area used to establish initial adoption and secure market traction, such as realigning pricing to alleviate payer resistance, or generating outcomes validation to justify […]

Levers for Launch: How Nuplazid Overcame Early Resistance to Establish the Standard of Care in Parkinson’s Disease Psychosis

Novel therapies entering previously untreated spaces often face steep adoption barriers when safety concerns or prescriber inertia arise. Overcoming this resistance requires establishing a strategic beachhead: a targeted focus area used to secure market traction, such as activating independent patient advocacy champions or publishing real-world surveillance data to resolve clinical skepticism. This case study is […]

Levers for Launch: How Entresto Overcame Early Commercial Headwinds to Reshape Heart Failure Care

Promising drugs often struggle early with slow uptake and missed sales targets. Achieving commercial traction requires securing a strategic beachhead: a targeted focus area such as concentrating on a guideline-backed patient group, eliminating a key payer barrier, or publishing real-world data to resolve prescriber hesitation. This case study is part of Triangle Insights Group’s series, […]

 Levers for Launch

How Five Analog Brands Used Positioning, Advocacy, Evidence, and Access Levers for Launch and Beyond Pharmaceutical product launches are complex and critical to get right. In today’s environment, marked by heightened payer scrutiny, crowded markets, and compressed timelines for demonstrating value, even promising therapies often face slow uptake and missed forecasts in their earliest months. […]

Skip to toolbar